Your browser is no longer supported. Please, upgrade your browser.
Settings
NVO Novo Nordisk A/S daily Stock Chart
NVO [NYSE]
Novo Nordisk A/S
Index- P/E16.78 EPS (ttm)2.13 Insider Own26.40% Shs Outstand2.00B Perf Week0.79%
Market Cap71.42B Forward P/E15.06 EPS next Y2.37 Insider Trans0.00% Shs Float1.30B Perf Month2.03%
Income5.40B PEG1.75 EPS next Q- Inst Own8.20% Short Float0.28% Perf Quarter13.21%
Sales15.92B P/S4.49 EPS this Y10.60% Inst Trans-15.80% Short Ratio1.25 Perf Half Y-23.71%
Book/sh2.57 P/B13.91 EPS next Y7.13% ROA42.70% Target Price36.70 Perf Year-29.36%
Cash/sh1.47 P/C24.23 EPS next 5Y9.60% ROE91.10% 52W Range30.89 - 57.26 Perf YTD-0.33%
Dividend1.12 P/FCF30.93 EPS past 5Y20.10% ROI84.70% 52W High-37.59% Beta0.71
Dividend %3.13% Quick Ratio1.00 Sales past 5Y11.00% Gross Margin84.60% 52W Low15.70% ATR0.58
Employees41971 Current Ratio1.30 Sales Q/Q2.40% Oper. Margin43.30% RSI (14)56.45 Volatility0.93% 1.47%
OptionableYes Debt/Eq0.01 EPS Q/Q6.70% Profit Margin33.90% Rel Volume0.72 Prev Close35.60
ShortableYes LT Debt/Eq0.00 EarningsFeb 02 BMO Payout65.20% Avg Volume2.93M Price35.74
Recom4.00 SMA202.34% SMA500.99% SMA200-17.68% Volume2,109,612 Change0.39%
Oct-31-16Downgrade DNB Markets Buy → Hold
Oct-31-16Downgrade Citigroup Buy → Neutral
Oct-28-16Downgrade BofA/Merrill Neutral → Underperform
Sep-23-16Initiated Piper Jaffray Neutral
Sep-13-16Upgrade Exane BNP Paribas Neutral → Outperform
Sep-09-16Downgrade JP Morgan Overweight → Neutral
Sep-01-16Downgrade Morgan Stanley Overweight → Equal-Weight
Aug-31-16Upgrade HSBC Securities Reduce → Hold
Aug-08-16Downgrade BofA/Merrill Buy → Neutral
Aug-28-15Initiated Leerink Partners Mkt Perform $56
Jun-09-15Upgrade Morgan Stanley Equal-Weight → Overweight
Apr-15-15Initiated Societe Generale Sell
May-28-13Upgrade Deutsche Bank Sell → Hold
Mar-31-10Initiated Deutsche Bank Hold
Mar-30-10Downgrade Mehta Partners Outperform → Market Perform
Feb-24-10Upgrade Jefferies & Co Hold → Buy
Jan-15-10Downgrade Jefferies & Co Buy → Hold
Sep-11-09Initiated Jefferies & Co Buy
Aug-07-09Downgrade UBS Buy → Neutral
Aug-07-09Downgrade JP Morgan Overweight → Neutral
Feb-27-17 10:39AM  DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Novo Nordisk A/S (NVO) and Lead Plaintiff Deadline: March 13, 2017 Accesswire
10:12AM  NVO SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Novo Nordisk A/S and a Lead Plaintiff Deadline of March 13, 2017 Business Wire
06:00AM  Drugmakers Eye $35B Market Amid Obesity Crisis at Investopedia
Feb-24-17 08:10PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Novo Nordisk A/S of Class Action Lawsuit and Upcoming Deadline - NVO Accesswire
10:02AM  Patient Dies In Roche Hemophilia Study at Investopedia
Feb-23-17 11:45PM  Pawar Law Group Announces that a Securities Class Action Lawsuit has been filed Against Novo Nordisk A/S - NVO Accesswire
10:38AM  SHAREHOLDER ALERT - - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Novo Nordisk A/S (NVO) and Lead Plaintiff Deadline: March 13, 2017 Accesswire
Feb-22-17 11:39AM  NVO INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Novo Nordisk A/S and a Lead Plaintiff Deadline of March 13, 2017 PR Newswire
09:30AM  Canadian News Media Challenged to See the Whole Picture When Reporting on Obesity PR Newswire
Feb-21-17 09:06AM  Sanofi Pasteur: Why Human Vaccines Matter
Feb-20-17 09:06AM  Sanofis Unique Foothold in Diabetes and Cardiovascular
Feb-17-17 10:50PM  NOVO NORDISK SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Novo Nordisk A/S (NVO) Business Wire
08:35PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Novo Nordisk A/S of Class Action Lawsuit and Upcoming Deadline - NVO Accesswire
09:58AM  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Novo Nordisk A/S of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 13, 2017 Business Wire
Feb-15-17 09:30AM  9 Top Pharmaceutical Stocks to Buy for the Dividends at Kiplinger
Feb-14-17 03:11PM  DEADLINE ALERT: Brower Piven Alerts Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those With Losses In Excess Of $100,000 From Investment In Novo Nordisk A/S To Contact The Firm Business Wire
01:58PM  NVO INVESTORS ALERT: Lieff Cabraser Announces Securities Class Action Against Novo Nordisk A/S Business Wire
10:18AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Novo Nordisk A/S (NVO) and Lead Plaintiff Deadline: March 13, 2017 Accesswire
Feb-13-17 01:29PM  NVO SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Novo Nordisk A/S and a Lead Plaintiff Deadline of March 13, 2017 Business Wire
Feb-10-17 08:10PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Novo Nordisk A/S of Class Action Lawsuit and Upcoming Deadline NVO GlobeNewswire
10:23AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Novo Nordisk A/S (NVO) and Lead Plaintiff Deadline - March 13, 2017 Accesswire
Feb-09-17 09:33AM  Great Place to Work® and Fortune Name Novo Nordisk as one of the country's best workplaces for giving back PR Newswire
09:30AM  The Zacks Analyst Blog Highlights: Priceline, NextEra Energy, Schwab, Anadarko and Novo Nordisk
Feb-08-17 03:59PM  Top Analyst Reports for Priceline, Schwab & NextEera Energy
01:23PM  NVO INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Novo Nordisk A/S and a Lead Plaintiff Deadline of March 13, 2017 GlobeNewswire
10:45AM  Just 2 of the 13 Largest Drugmakers Have More Cash Than Debt -- Can You Guess Who They Are? at Motley Fool
Feb-07-17 02:14PM  Novo Nordisk A/S :NVO-US: Earnings Analysis: 2016 By the Numbers : February 7, 2017
12:33PM  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Novo Nordisk A/S NVO GlobeNewswire
10:45AM  Hemophilia Drug Market Competitive Ramps Up at Investopedia
10:37AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Novo Nordisk A/S (NVO) and Lead Plaintiff Deadline - March 13, 2017 Accesswire
10:30AM  Beaten-Down Valuation and a 3% Dividend Yield
Feb-06-17 06:26PM  Value Screeners Identify Top Sectors
10:50AM  Novo Nordisk A/S :NVO-US: Earnings Analysis: Q4, 2016 By the Numbers : February 6, 2017
Feb-03-17 10:50PM  NOVO NORDISK SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Novo Nordisk A/S - (NVO) PR Newswire
07:02PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Novo Nordisk A/S of Class Action Lawsuit and Upcoming Deadline - NVO PR Newswire
04:02PM  Novo Nordisk Q4 Net Below Street Expectations at Investopedia
04:01PM  Novo Nordisk A/S Closes the Books on a Tough Year at Motley Fool
02:16PM  Novo Nordisk (NVO) Misses Q4 Earnings, Revenues Down Y/Y
01:05PM  SHAREHOLDER ALERT: CLASS PERIOD EXPANDED IN CLASS ACTION LAWSUIT Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Novo Nordisk A/S (NVO) To Contact Brower Piven Before The Lead Plaintiff Deadline GlobeNewswire
11:41AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Novo Nordisk A/S of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 13, 2017 NVO GlobeNewswire
09:06AM  Why the Majority of Analysts Deem Novartis a Buy
08:46AM  Good News and Bad News for MannKind Corporation at Motley Fool
Feb-02-17 12:57PM  Deutsche Bank, Daimler yank Germanys DAX to close lower after earnings at MarketWatch -8.75%
12:23PM  European shares fall weighed down by poor earnings; Reckitt up
10:55AM  [$$] Novo Nordisk cuts profit outlook on higher US political risks at Financial Times
10:40AM  5 Drugmakers Battle Over the $10 Billion Hemophilia Market at Motley Fool
10:10AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Novo Nordisk A/S (NVO) and Lead Plaintiff Deadline - March 13, 2017 GlobeNewswire
05:54AM  Novo Nordisk misses 4Q profit forecasts
04:23AM  Novo Nordisk Slumps on Disappointing Profit, Guidance Cut
03:28AM  European shares edge lower on disappointing company updates
01:55AM  Novo Nordisk Trims Outlook on Increased U.S. Political Risks at Bloomberg
Feb-01-17 07:40PM  Falling US prices hurt Danish Novo Nordisk profit AFP
10:30AM  Glancy Prongay & Murray Announces the Filing of a Securities Class Action on Behalf of Novo Nordisk A/S Investors and Encourages Investors to Contact the Firm Business Wire
09:16AM  5 Dividend Stocks to Buy in February at Motley Fool
Jan-31-17 10:37AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Novo Nordisk A/S (NVO) and Lead Plaintiff Deadline - March 13, 2017 Accesswire
Jan-30-17 10:06PM  Sanofi, Novo Nordisk, Lilly being sued AAP
05:27PM  Novo Nordisk Inks Diabetes Deal with University of Oxford
03:18PM  Sanofi, Novo Nordisk and Lilly named in patients' price fixing suit Reuters
10:27AM  INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Novo Nordisk A/S of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 13, 2017 - NVO Accesswire
10:03AM  [$$] Oxford university to host £115m diabetes research centre at Financial Times
07:43AM  Here's the Best Dividend Stock in Big Pharma at Motley Fool
Jan-27-17 03:12PM  SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Novo Nordisk A/S To Contact The Firm Before Lead Plaintiff Deadline PR Newswire
10:30AM  The Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Novo Nordisk A/S Investors and Encourages Investors to Contact the Firm Business Wire
Jan-26-17 06:28PM  Robbins Arroyo LLP: Novo Nordisk A/S (NVO) Misled Shareholders According to a Recently Filed Class Action Business Wire
10:36AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Novo Nordisk A/S (NVO) and Lead Plaintiff Deadline - March 13, 2017 Accesswire
Jan-25-17 05:52PM  SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Novo Nordisk A/S and Certain Officers NVO GlobeNewswire
Jan-24-17 07:42PM  NVO LOSS NOTICE: Rosen Law Firm Reminds Novo Nordisk A/S Investors of Important Deadline in Class Action NVO Business Wire
05:16PM  INVESTOR ALERT: Law Offices of Howard G. Smith Commences Investigation on Behalf of Novo Nordisk A/S Investors Business Wire
09:30AM  LESS THAN 2 MONTHS REMAIN FOR NOVO NORDISK A/S INVESTORS: Hagens Berman Alerts Novo Nordisk Investors to Expanded Class Period and Reminds Them of Lead Plaintiff Deadline GlobeNewswire
Jan-23-17 03:12PM  Levi & Korsinsky Files in U.S. District Court to Recover Losses Suffered by Investors in Novo Nordisk A/S (NVO)
10:36AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Novo Nordisk A/S (NVO) and Lead Plaintiff Deadline: March 13, 2017 Accesswire
Jan-20-17 11:23PM  NOVO NORDISK SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Novo Nordisk A/S - (NVO) Marketwired
06:23PM  7 Stocks for 2017
02:17PM  SHAREHOLDER ALERT: CLASS PERIOD EXPANDED IN CLASS ACTION LAWSUIT Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Novo Nordisk A/S To Contact Brower Piven Before The Lead Plaintiff Deadline Business Wire
10:35AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Novo Nordisk A/S (NVO) and Lead Plaintiff Deadline: March 13, 2017 Accesswire
10:30AM  Glancy Prongay & Murray LLP Commences Investigation on Behalf of Novo Nordisk A/S Investors Business Wire
Jan-17-17 11:48AM  NVO SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving Novo Nordisk A/S and a Lead Plaintiff Deadline of March 13, 2017 GlobeNewswire
Jan-16-17 10:10AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Novo Nordisk A/S (NVO) and Lead Plaintiff Deadline: March 13, 2017 GlobeNewswire
09:07AM  How Did Novartis Perform in 3Q16?
Jan-13-17 10:50PM  NOVO NORDISK SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Novo Nordisk A/S (NVO) GlobeNewswire
02:20PM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Novo Nordisk A/S (NVO) and Lead Plaintiff Deadline: March 13, 2017 Accesswire
11:19AM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novo Nordisk A/S - NVO PR Newswire
Jan-12-17 10:40PM  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Novo Nordisk A/S NVO Business Wire
08:00PM  SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Novo Nordisk A/S (NVO) To Contact Brower Piven Before The Lead Plaintiff Deadline GlobeNewswire
03:25PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Novo Nordisk A/S of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 13, 2017 NVO GlobeNewswire
03:07PM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Novo Nordisk A/S (NVO) and Lead Plaintiff Deadline: March 13, 2017 Accesswire
03:01PM  2 MONTHS REMAIN FOR NOVO NORDISK A/S INVESTORS: Hagens Berman Alerts Novo Nordisk Investors to Securities Class Action and Lead Plaintiff Deadline GlobeNewswire
12:20PM  Drug makers, auto stocks yank European stocks lower for first time in 3 days at MarketWatch
10:15AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Novo Nordisk A/S (NVO) and Lead Plaintiff Deadline: March 13, 2017 PR Newswire
08:42AM  Stock Futures Hold Lower as Jobless Claims, Import Prices Rise
04:55AM  Novo Nordisk shares hit by U.S. lawsuit, Trump comments
04:45AM  Novo Nordisk slumps 5.4% on U.S. price fixing lawsuit at MarketWatch
Jan-11-17 07:29PM  SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Novo Nordisk A/S To Contact The Firm Before Lead Plaintiff Deadline GlobeNewswire
05:59PM  Bernstein Litowitz Berger & Grossmann LLP Announces Securities Class Action Suit Filed Against Novo Nordisk A/S and Certain of its Senior Executives PR Newswire
08:27AM  Novo Nordisk (NVO) Fiasp Gets EU Nod for Diabetes in Adults
Jan-09-17 01:53PM  ETFs with exposure to Novo Nordisk A/S : January 9, 2017
Jan-07-17 10:53AM  In the age of Uber and Lyft, its still hard for some Americans to get to the doctor at MarketWatch
Jan-05-17 05:42PM  Top 7 Dividend Health Care Stocks
Dec-30-16 03:53PM  Here's What Good Managers Do When Things Don't Go Their Way at Forbes
12:05PM  AstraZenecas Focused Strategy to Boost Future Revenues
Novo Nordisk A/S, a healthcare company, engages in the discovery, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity Care, and Biopharmaceuticals. The Diabetes and Obesity Care segment provides insulins, GLP-1 analog, and oral anti-diabetic drugs, as well as other protein related products comprising glucagon, protein related delivery systems, and needles. The Biopharmaceuticals segment offers products in the areas of haemophilia care, growth hormone therapy, and hormone replacement therapy. The company markets and distributes its products through distributors and independent agents. Novo Nordisk A/S was founded in 1925 and is headquartered in Bagsvaerd, Denmark.